Clinical TrialID 7631
Thymol on Netrin-1 on Obese Patients
NCT05427721
Inflammatory Response|Obesity
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 7631
- Evidence Id
- 7631
- Core Evidence Id
- 7631
- Source Clinical Trial Id
- 7628
- Herb2 Clinical Trial Id
- HBCT007628
- Nct Id
- NCT05427721
- Title
- Thymol on Netrin-1 on Obese Patients
- Status
- Phase
- Phase 2
- Study Result
- No
- Study Condition
- Inflammatory Response|Obesity
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
- Intervention
- DRUG: Thymol
- Intervention Allocation
- Randomized
- Intervention Model
- Crossover
- Intervention Mask
- Double
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult
- Enrollment
- 30
- Outcome Measure
- Netrin-1, Enzyme-Linked ImmunoSorbent Assay, Change from baseline netrin-1 at 90 days
- Sponsor Collaborator
- Centro Universitario de Ciencias de la Salud, Mexico
- Funded By
- OTHER
- Location
- INTEC, CUCS, Universidad de Guadalajara, Guadalajara, Jalisco, 4430, Mexico
- Other Id
- CI-01621|20-131
- Start Date
- 2022-04-01
- Primary Completion Date
- 2022-12-15
- Completion Date
- 2022-12-30
- First Posted
- 2022-06-22
- Results First Posted
- Last Update Posted
- 2022-06-22
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT05427721
- Title Cn
- Title En
- Thymol on Netrin-1 on Obese Patients
- Bilingual Status
- semi_complete